In vitro and in vivo study of ABT-869 in treatment acute myeloid leukemia (AML) alone or in combination with chemotherapy or HDAC inhibitors: insight into molecular mechanism and biologic characterization
Ph.D
Saved in:
Main Author: | ZHOU JIANBIAO |
---|---|
Other Authors: | MEDICINE |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/16573 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011) -
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011) -
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011) -
Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer
by: Tan, E.-H., et al.
Published: (2014) -
X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery
by: Zhou, J., et al.
Published: (2021)